Case-mix adjusted percentage of cancers diagnosed at stages 1 and 2 in England, 2019

The Cancer survival in England publication provides estimates of adult cancer survival for common cancer types. Survival by stage at diagnosis is estimated where possible. This publication also provides cancer survival estimates for children diagnosed with cancer. This publication has been combined with the geographic patterns of cancer survival in England publication, providing estimates of adult cancer survival for common cancer types, by the regional geographies of Cancer Alliances (CAs) and Sustainability and Transformation Partnerships (STPs).

Public Health Outcomes Framework (PHOF) currently publishes the cancers diagnosed at stages 1 and 2 at a variety of geographies (including local authority and regions). For publications including 2018 diagnoses onwards, the definition has been aligned to the complete case approach presented in the current document. For previous publications the definition currently comprised new cases of cancer diagnosed at stage 1 and 2 as a proportion of all new cases of cancer diagnosed (specific cancer sites, morphologies and behaviour: invasive malignancies of breast, prostate, colorectal, lung, bladder, kidney, ovary, uterus, non-Hodgkin lymphomas and invasive melanomas of skin).

CCG Outcome Indicator Set publishes the following variables the percentage of all cases of cancer for which a valid stage is recorded by CCG, cancers detected at stage 1 or 2 (as defined as above), and record of lung cancer stage at decision to treat. From May 2020, the definition was aligned to the complete case approach presented in the current document.

United Kingdom and Ireland Association of Cancer Registries (UKIACR) publishes data related to performance indicators, including stage complete by cancer site groups, for each of the cancer registries.